Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137052) titled 'A Prospective Multi-center Clinical Study on Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar by Multi-dimensional Molecular Imaging' on Aug. 14.
Study Type: Observational [Patient Registry]
Primary Sponsor: The First Affiliated Hospital of Xiamen University
Condition:
PET / CT
Nasopharyngeal Carcinoma (NPC)
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 732
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07137052
Published by HT Digital Content Services with permission from Health Daily Digest....